Shandong Wohua Pharmaceutical Co., Ltd.

002107

CNE000001QB8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 23/06/2024 BST			5-day change	1st Jan Change
3.83 ^CNY	-5.43%		-7.49%	-36.90%

05-20	Shandong Wohua Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented on A Shares, Payable on 24 May 2024	CI
04-26	Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Shandong Wohua Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented on A Shares, Payable on 24 May 2024

May 20, 2024 at 08:33 pm

Shandong Wohua Pharmaceutical Co., Ltd. announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.50000000 for the year 2023, payable on 24 May 2024. Record date is 23 May 2024. Ex-date is 24 May 2024.

Latest news about Shandong Wohua Pharmaceutical Co., Ltd.

Shandong Wohua Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented on A Shares, Payable on 24 May 2024	05-20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Profit Distribution for 2023	04-01	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/07/23	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	15/07/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	15/04/22	CI
Wohua Pharmaceutical Sets Payment Date For 2021 Final Dividend	02/03/22	MT
Shandong Wohua Pharmaceutical Co., Ltd. Approves Dividend for the Year 2021, Payable on March 8, 2022	11/02/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Announces Executive Appointments	11/02/22	CI
Wohua Pharmaceutical Declares Final 2021 Dividend	24/01/22	MT
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Dividend for the Year 2021	21/01/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	20/01/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	29/07/21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	06/04/21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Declares Cash Dividend for A Shares for 2020, Payable on 09 April 2021	31/03/21	CI
Beijing Tongfengtang Pharmaceutical Management Co., Ltd. cancelled the acquisition of Wohua Pharmaceutical International Co., Ltd. from Shandong Wohua Pharmaceutical Co., Ltd..	26/03/21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Approves Distribution for 2020	22/02/21	CI
Shandong Wohua Pharmaceutical : Pharma Declares Cash Dividend	21/01/21	MT
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2020	21/01/21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	20/01/21	CI

Chart Shandong Wohua Pharmaceutical Co., Ltd.

Duration

Period

Chart Shandong Wohua Pharmaceutical Co., Ltd.

More charts

Company Profile

Shandong Wohua Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese traditional patent medicines. The Company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Gushu tablets for the treatment of middle-aged and senile osteoporosis, and Hedan tablets for promoting blood circulation and for the treatment of hyperlipidemia. The Company distributes its products in domestic market, mainly in East China, North China and Northeast China.

Sector

Pharmaceuticals

Calendar

28/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
SHANDONG WOHUA PHARMACEUTICAL CO., LTD.	-36.90%	305M
DONG-E-E-JIAO CO.,LTD.	+29.76%	5.68B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-32.34%	3.59B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	0.00%	3.12B
TASLY PHARMACEUTICAL GROUP CO., LTD	-25.09%	2.62B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-10.35%	2.3B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.88B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+40.90%	1.45B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.16%	1.39B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+42.86%	1.37B